Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VICL (Vical Labs) -- Ignore unavailable to you. Want to Upgrade?

To: Pseudo Biologist who wrote (531)	1/21/1998 9:52:00 PM
From: N	Read Replies (1) \| Respond to of 1972

PB and Bill, You're welcome. Although thanks should be more directed to Engbring than me. He certainly is personable and provides really a nice amount of detail, as you have pointed out before, a good discussion, forthright about what can and cannot be said/known etc. Well spoken, that's the phrase I'm looking for. There was also a flavor, not specific, that I got from him in discussing supporting empirical work that just sounded measured, solid, a good reflection of the firm...something about how FDA loosening up has encouraged others to cut corners, hence find submittals in trouble...on other hand VICL, he stresses, has had a good relationship with FDA, and values good research. Of course, he's supposed to say this...but I was impressed. Is this your impression, as well? He also spoke compassionately about his responsibility and experience in interviewing potential trial participants... PB, Sorry...what is agreement with DynaVax? Also, Engbring suggested searching for web site 'dna vaccine' (not url) for abstracts, news....maybe this has already been mentioned here. Nancy